BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 31689320)

  • 1. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.
    Lehner LJ; Reinke P; Hörstrup JH; Rath T; Suwelack B; Krämer BK; Budde K; Banas B
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29052906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial.
    Gustavsen MT; Midtvedt K; Lønning K; Jacobsen T; Reisaeter AV; De Geest S; Andersen MH; Hartmann A; Åsberg A
    Transpl Int; 2019 Jun; 32(6):614-625. PubMed ID: 30770608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study.
    Lieb M; Hepp T; Schiffer M; Opgenoorth M; Erim Y
    BMC Nephrol; 2020 Mar; 21(1):114. PubMed ID: 32234021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial.
    McGillicuddy JW; Chandler JL; Sox LR; Taber DJ
    Ann Pharmacother; 2020 Dec; 54(12):1185-1193. PubMed ID: 32506922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
    Fellström B; Holmdahl J; Sundvall N; Cockburn E; Kilany S; Wennberg L
    Transplant Proc; 2018 Dec; 50(10):3275-3282. PubMed ID: 30577197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Mobile Health Intervention on Long-term Nonadherence After Lung Transplantation: Follow-up After a Randomized Controlled Trial.
    Geramita EM; DeVito Dabbs AJ; DiMartini AF; Pilewski JM; Switzer GE; Posluszny DM; Myaskovsky L; Dew MA
    Transplantation; 2020 Mar; 104(3):640-651. PubMed ID: 31335759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial.
    Reese PP; Bloom RD; Trofe-Clark J; Mussell A; Leidy D; Levsky S; Zhu J; Yang L; Wang W; Troxel A; Feldman HI; Volpp K
    Am J Kidney Dis; 2017 Mar; 69(3):400-409. PubMed ID: 27940063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients.
    Taber DJ; Pilch NA; McGillicuddy JW; Mardis C; Treiber F; Fleming JN
    Am J Health Syst Pharm; 2019 Jul; 76(15):1143-1149. PubMed ID: 31361870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT).
    Foster BJ; Pai ALH; Zelikovsky N; Amaral S; Bell L; Dharnidharka VR; Hebert D; Holly C; Knauper B; Matsell D; Phan V; Rogers R; Smith JM; Zhao H; Furth SL
    Am J Kidney Dis; 2018 Jul; 72(1):30-41. PubMed ID: 29602631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Apparent Influence of Nonadherence on Tacrolimus Intrapatient Variability in Stable Kidney Transplant Recipients.
    Gokoel SRM; Zwart TC; Moes DJAR; van der Boog PJM; de Fijter JW
    Ther Drug Monit; 2020 Oct; 42(5):702-709. PubMed ID: 32941396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of prevalence and correlates of nonadherence to immunosuppressive medications in renal transplant recipients of South Indian population and their impact on long-term graft function.
    Saravanakumar K; Prakash A; Thopalan B; Dhanapriya J; Thanigachalam D; Ramanathan S; Gopalakrishnan N
    Saudi J Kidney Dis Transpl; 2019; 30(3):686-693. PubMed ID: 31249234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating barriers to immunosuppressant medication adherence in renal transplant patients.
    Cossart AR; Staatz CE; Campbell SB; Isbel NM; Cottrell WN
    Nephrology (Carlton); 2019 Jan; 24(1):102-110. PubMed ID: 29278439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
    Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
    Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
    Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
    Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?
    Nerini E; Bruno F; Citterio F; Schena FP
    J Nephrol; 2016 Oct; 29(5):627-36. PubMed ID: 26885659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study.
    Massey EK; Tielen M; Laging M; Beck DK; Khemai R; van Gelder T; Weimar W
    J Psychosom Res; 2013 Sep; 75(3):229-34. PubMed ID: 23972411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE) study.
    Tsapepas D; Langone A; Chan L; Wiland A; McCague K; Chisholm-Burns M
    Ann Transplant; 2014 Apr; 19():174-81. PubMed ID: 24743224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods.
    Liu J; Liu S; Yan J; Yi Q; Huang H
    Clin Ther; 2015 Nov; 37(11):2572-80. PubMed ID: 26519232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
    Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
    Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.